Steven L. Cook, the Chief Financial Officer of Omada Health, Inc. (NASDAQ:OMDA), has completed a series of equity transactions that resulted in the sale of company stock valued at $55,145. According to a Form 4 filing submitted to the Securities and Exchange Commission, the divestment activity occurred over a two-day period in late June 2026. The total volume of shares disposed of during this window amounted to 2,900 units.
The initial phase of the transaction took place on June 24, 2026, when Mr. Cook sold 2,600 shares of Omada Health common stock. The execution of these trades occurred within a narrow price band, with individual transactions ranging from $19.00 to $19.04. The weighted average price for this specific batch was recorded at $19.0173 per share. The following day, June 25, 2026, Mr. Cook completed the remainder of the disposal by selling an additional 300 shares. These final shares were transacted at a weighted average price of $19.0033, with individual trade prices falling between $19.00 and $19.01. The combined proceeds from these sales ranged between $19.0033 and $19.0173 per share.
Both sets of transactions were executed in accordance with a 10b5-1 trading plan that Mr. Cook adopted on March 14, 2026. This pre-arranged framework is typically utilized to facilitate the sale of company stock in a manner that avoids potential conflicts of interest or allegations of insider trading. Following the completion of these sales, Mr. Cook's direct ownership stake in Omada Health stands at 166,359 shares.
The executive divestment comes against a backdrop of notable market activity for Omada Health. The company's stock price has since climbed to $20.89, marking an 18% gain over the past week. Despite this recent upward momentum, analysis provided by InvestingPro suggests that the stock remains overvalued when measured against its calculated Fair Value. The firm maintains a robust balance sheet structure, holding more cash than debt, and reports a strong gross profit margin of 66%. Furthermore, analysts project that Omada Health is positioned to achieve profitability in the current year, supported by revenue growth of 49% over the last twelve months.
In related corporate developments, Omada Health recently reported its financial results for the first quarter of 2026. The company delivered an earnings per share (EPS) of -$0.05, which outperformed the consensus expectation of -$0.08. Revenue for the quarter reached $78 million, representing a 42% increase compared to the previous year. In response to these results, Citizens raised its price target for Omada Health from $18 to $21, while maintaining a Market Outperform rating. Analyst Constantine Davides noted that Omada Health was trading at 2.5 times the firm's 2026 revenue estimate.
On the governance front, the company held its 2026 Annual Meeting of Stockholders, where Sean Duffy and Trevor Fetter were elected as Class I Directors. Both individuals are set to serve until the 2029 annual meeting. These recent events highlight a period of active strategic and operational movement for the digital health provider.